Segmental stiff skin syndrome (SSS): A distinct clinical entity

被引:29
|
作者
Myers, Kathryn L. [1 ]
Mir, Adnan [1 ,2 ]
Schaffer, Julie V. [1 ,3 ]
Meehan, Shane A. [1 ]
Orlow, Seth J. [1 ]
Brinster, Nooshin K. [1 ]
机构
[1] NYU, Sch Med, Ronald O Perelman Dept Dermatol, 240 E 38 St,11th Floor, New York, NY 10016 USA
[2] Univ Texas Southwestern & Childrens Med Ctr Dalla, Dept Dermatol, Dallas, TX USA
[3] Hackensack Univ, Med Ctr, Dept Dermatol, Hackensack, NJ USA
关键词
adipocyte entrapment; congenital fascial dystrophy; fibrillin-1; fibrosis; segmental stiff skin syndrome; stiff skin syndrome; CONGENITAL FASCIAL DYSTROPHY; DIAGNOSIS; SCLERODERMA;
D O I
10.1016/j.jaad.2016.01.038
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Stiff skin syndrome (SSS) is a noninflammatory, fibrosing condition of the skin, often affecting the limb girdles. Objective: We present 4 new patients with SSS with largely unilateral, segmental distribution. To date, reported cases of SSS have been grouped based on generally accepted clinical and histopathologic findings. The purpose of this study was to analyze differences in clinical and histopathologic findings between previously reported SSS cases. Methods: This is a retrospective review of 4 new cases and 48 previously published cases of SSS obtained from PubMed search. Results: Of 52 total cases, 18 (35%) were segmentally distributed and 34 (65%) were widespread. The average age of onset was 4.1 years versus 1.6 years for segmental versus widespread SSS, respectively. Limitation in joint mobility affected 44% of patients with segmental SSS and 97% of patients with widespread SSS. Histopathologic findings were common between the 2 groups. Limitations: This was a retrospective study of previously published cases limited by the completeness and accuracy of the reviewed cases. Conclusions: We propose a distinct clinical entity, segmental SSS, characterized by a segmental distribution, later age of onset, and less severe functional limitation. Both segmental SSS and widespread SSS share common diagnostic histopathologic features.
引用
收藏
页码:163 / 168
页数:6
相关论文
共 50 条
  • [21] Stiff skin syndrome
    Geng, S.
    Lei, X.
    Toyohara, J. P.
    Zhan, P.
    Wang, J.
    Tan, S.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2006, 20 (06) : 729 - 732
  • [22] Multiple drug allergy syndrome: A distinct clinical entity
    Asero R.
    [J]. Current Allergy and Asthma Reports, 2001, 1 (1) : 18 - 22
  • [23] ACUTE SENSORY NEURONOPATHY SYNDROME - DISTINCT CLINICAL ENTITY
    STERMAN, AB
    SCHAUMBURG, HH
    ASBURY, AK
    [J]. ANNALS OF NEUROLOGY, 1979, 6 (02) : 147 - 147
  • [24] THE ACUTE SENSORY NEURONOPATHY SYNDROME - A DISTINCT CLINICAL ENTITY
    STERMAN, AB
    SCHAUMBURG, HH
    ASBURY, AK
    [J]. ANNALS OF NEUROLOGY, 1980, 7 (04) : 354 - 358
  • [25] Is complex sleep apnea syndrome a distinct clinical entity?
    Kagramanov, V
    Morgenthaler, TI
    [J]. SLEEP, 2005, 28 : A170 - A170
  • [26] Ultrasound Morphology of Stiff Skin Syndrome with Clinical and Histological Correlation
    Kaplan, V.
    Bolte, C.
    Sazunic, I.
    Wortsman, X.
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2019, 110 (03): : 247 - 248
  • [27] DYSMORPHIC SYNDROME AND STIFF SKIN SYNDROME
    AMORIC, JC
    STALDER, JF
    DAVID, A
    BUREAU, B
    PIERARD, GE
    LITOUX, P
    [J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1991, 118 (11): : 802 - 804
  • [28] Rowell's syndrome: a distinct clinical entity or a coincidence of diagnoses?
    Lent, Megan
    Jagwani, Sonya
    Ward, Dana
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2012, 51 (06) : 718 - 721
  • [29] Relapsing polychondritis: A syndrome rather than a distinct clinical entity?
    Priori, R
    Conti, F
    Pittoni, V
    Valesini, G
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1997, 15 (03) : 334 - 335
  • [30] Multiple Drug Intolerance Syndrome: An Underreported Distinct Clinical Entity
    Behera, Sapan K.
    Das, Saibal
    Chengappa, Kavadichanda G.
    Xavier, Alphienes S.
    Selvarajan, Sandhiya
    [J]. CURRENT CLINICAL PHARMACOLOGY, 2019, 14 (02): : 84 - 90